. 2017 Sep 16;8(49):86143–86156. doi: 10.18632/oncotarget.21026

Table 1. Number of detected CTCs isolated from frozen DLA of pancreatic cancer patients in sample set A (2 vials, 2 x 10⁸ cells/mL). Overall detection rate of CTCs was 42% (44% M1, 40% M0). No significant correlations with any clinical parameter were found.

Sample ID	Tumor type	Stage	Grade	CTCs	Histology	Age	Sex
5931	Pancreatic	2a	2	0	moderately differenciated ductal adenocarcinoma	57	m
5804	pancreatic	2b	2	2	moderately differenciated adenocarcinoma	69	m
5549	pancreatic	2b	2	2	moderately differenciated ductal adenocarcinoma	52	f
5714	pancreatic	2b	3	0	poorly differenciated adenocarcinoma	86	m
5751	pancreatic	2b	2	0	moderately differenciated ductal adenocarcinoma	54	m
5902	pancreatic	2b	2	0	moderately differenciated ductal adenocarcinoma	73	m
6033	pancreatic	2b	3	1	poorly differenciated ductal adenocarcinoma	63	m
6104	pancreatic	2b	2	0	moderately differenciated ductal adenocarcinoma	55	f
5689	pancreatic	2b	3	2	moderately differenciated ductal adenocarcinoma	55	m
6017	pancreatic	3	2	0	moderately differenciated ductal adenocarcinoma	70	f
5447	pancreatic	4	2	0	moderately differenciated mucinous ductal adenocarcinoma	72	m
5580	pancreatic	4	2	0	moderately differenciated ductal adenocarcinoma	51	f
5792	pancreatic	4	3	1	poorly differenciated ductal adenocarcinoma	72	f
6012	pancreatic	4	3	0	poorly differenciated ductal adenocarcinoma	66	f
6098	pancreatic	4	2	0	moderately differenciated ductal adenocarcinoma	54	f
6016	pancreatic	4	3	0	poorly differenciated adenocarcinoma	58	f
5539	pancreatic	4	3	7	poorly differenciated adenocarcinoma	85	m
5803	pancreatic	4	3	2	poorly differenciated ductal adenocarcinoma	72	f
5904	pancreatic	4	2	7	moderately differenciated ductal adenocarcinoma	73	f

Table 1. Number of detected CTCs isolated from frozen DLA of pancreatic cancer patients in sample set A (2 vials, 2 x 108 cells/mL). Overall detection rate of CTCs was 42% (44% M1, 40% M0). No significant correlations with any clinical parameter were found.